Clinical Trial Update: A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating commercial DEFINITY to monitor effects of the heart's pulmonary artery pressure; study completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Heart Disease

Drugs mentioned

• DEFINITY (perflutren lipid microspheres)

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Pulmonary Heart Disease | Phase 4 | Status: COMPLETED | Results posted: 2011-07-11